TY  - GEN
AU  - Bachanova,V
AU  - Marks,D I
AU  - Zhang,M-J
AU  - Wang,H
AU  - de Lima,M
AU  - Aljurf,M D
AU  - Arellano,M
AU  - Artz,A S
AU  - Bacher,U
AU  - Cahn,J-Y
AU  - Chen,Y-B
AU  - Copelan,E A
AU  - Drobyski,W R
AU  - Gale,R P
AU  - Greer,J P
AU  - Gupta,V
AU  - Hale,G A
AU  - Kebriaei,P
AU  - Lazarus,H M
AU  - Lewis,I D
AU  - Lewis,V A
AU  - Liesveld,J L
AU  - Litzow,M R
AU  - Loren,A W
AU  - Miller,A M
AU  - Norkin,M
AU  - Oran,B
AU  - Pidala,J
AU  - Rowe,J M
AU  - Savani,B N
AU  - Saber,W
AU  - Vij,R
AU  - Waller,E K
AU  - Wiernik,P H
AU  - Weisdorf,D J
TI  - Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease
SN  - 1476-5551
PY  - 2014///0430
KW  - Adult
KW  - Animals
KW  - Bone Marrow Transplantation
KW  - Female
KW  - Guinea Pigs
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Neoplasm, Residual
KW  - Philadelphia Chromosome
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - pathology
KW  - Protein-Tyrosine Kinases
KW  - antagonists & inhibitors
KW  - Remission Induction
KW  - Survival Rate
KW  - Transplantation Conditioning
KW  - Transplantation, Homologous
KW  - Young Adult
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/leu.2013.253
ER  -